Ahmed.Masao - PDL1 and IL2 combination therapy in CD8 T cells
Investigation Details
Investigation Information
| Name: | Ahmed.Masao - PDL1 and IL2 combination therapy in CD8 T cells |
| Principal Investigator: | Rafi Ahmed |
| Institution: | Emory University |
| Contact Email: | Not specified |
| Created: | 2025-08-21 16:57 |
| Last Updated: | 2025-12-21 21:04 |
| Status: | Completed |
Description
Masao Hashimoto's project on PDL1 and IL2 mono- and combination therapies and their effects on CD8+ T cells in mice in the context of LCMV
Associated Publication
PD-1 combination therapy with IL-2 modifies CD8(+) T cell exhaustion program.
Authors: Hashimoto M, Araki K, Cardenas MA et al.
Journal: Nature (2022)
PMID: 36171288
Quick Statistics
2
Studies2
Assays21
SamplesAssociated Studies
New Study| Study Name | Type | Organism | Assays | Samples | Created | Actions |
|---|---|---|---|---|---|---|
| Ahmed.Masao.CD8.rerun_2023 | Single-cell ATAC-seq | Mus musculus | 1 | 6 | 2025-08-21 | |
| Ahmed.Masao.CD8_2022 | Single-cell ATAC-seq | Mus musculus | 1 | 15 | 2025-08-22 |